Biopharma News : Biopharma and Pharma news from all around the world :
- PROMETRIKA Presents Exploring the Impact of Decentralized Clinical Trials – A Live Webcast
- Agilent Launches Partnership with Delaware State University to Advance Diversity in Science, Technology, Engineering and Math (STEM) Fields
- MaaT Pharma Publishes its Half Year Results and Provides a Business Overview
- Imvax Presents New Data on Personalized Whole-Tumor Derived Immunotherapeutic Platform at 2022 International Cancer Immunotherapy Conference
- Global Transfection Technologies Market Report (2022 to 2027) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com
- Australia Regenerative Medicine Market Report 2022: Expanding Healthcare Infrastructure and Increasing Evolution in the Pharmaceutical Sector Drives Sector – ResearchAndMarkets.com
- Global Clinical Microbiology Instruments and Reagents Market Report 2022: Digitalization and Robotization Trend to Boost Sector – ResearchAndMarkets.com
- Maxwell Biosciences Announces In Vivo and In Vitro Data on CLAROMER™ Platform’s Ability to Treat and Prevent SARS-CoV-2 and Other Respiratory Viruses at OPTIONS XI Conference
- Cerba Lancet Africa Signs Strategic Partnership With International Clinical Laboratories in Ethiopia
- Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification
- iXCells Biotechnologies Secures Strategic Growth Investment from Great Point Partners
- Sierra Space, UC San Diego Partner to Develop the First Stem Cell Research Institute in Space
- SunLink Health Systems, Inc. Announces Fiscal 2022 Fourth Quarter and Annual Results and COVID-19 Update
- Global Animal Model Market Report 2022: Increase in Funding for R&D Activities Fueling Growth – ResearchAndMarkets.com
- Kahun Secures $8M Round for its ‘XAI’ Engine for Clinical Reasoning
- MAIA Biotechnology to Present at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
- Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022
- Humana Receives High Rankings in the Hispanic Association on Corporate Responsibility’s Corporate Inclusion Index
- Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements
- Propanc Biopharma Targets Pancreatic & Ovarian Cancers for PRP Clinical Studies with Combined Markets to Reach Over $14.3 Billion by 2027
- EPTAM Precision and Sterling Join Forces to Become the Partner of Choice for Medical Molding Customers
- Prilenia Expands Leadership Team, Appoints Anne Sullivan as Chief Business Officer
- ImmunoGen Presents Comprehensive Updates for Mirvetuximab Soravtansine Combination Data in Ovarian Cancer at IGCS
- Strengthening Healthcare Systems to Meet Patients’ Need for Plasma-Derived Therapies
- Meliora Therapeutics Raises $11M Seed Financing to Develop First Mechanism Of Action Atlas in Oncology
- Adrestia appoints Will Lewis as Chair, establishes US Operations and appoints new functional leads
- CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
- Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada’s Trade Commissioner Service
- Enanta Pharmaceuticals Presents Preclinical Data for its Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Programs at the 12th International RSV Symposium
- Rite Aid Corporation Reports Fiscal 2023 Second Quarter Results
Biotech – Biopharma News!
- Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
- DEFENCE THERAPEUTICS IS GRANTED PATENTS IN JAPAN AND ISRAEL EXPANDING ITS NOVEL ADC PLATFORM TECHNOLOGY IN THE FAST GROWING ANTIBODY-DRUG CONJUGATES MARKET
- Xlife Sciences with pleasing progress in the first half of 2022
- ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022
- Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand
- BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company
- MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council
- Project company Laxxon Medical achieves major milestone
- Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report H1 2022 Financial Results and Operational Progress on September 30, 2022
- Biotest AG: Biotest AG opens 13th plasma collection centre in the Czech Republic
- Zur Rose Group announces a tender offer for all of its CHF 115 million outstanding bonds due 2023
- Spexis announces positive renal impairment clinical trial results with balixafortide
- Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children’s Hospital of Chicago
- Medacta announces first revision surgeries in the US using the unique-on-the-market and innovative MyKnee R patient-specific solution
- Defence Therapeutics Inc.: BREAKTHROUGH RESULTS WITH ACCUM(TM) A1-REPROGRAMMED MSC, MESENCHYMAL STEM CELLS, IN A NOVEL VACCINE CURED 80% OF ANIMALS WITH PRE-ESTABLISHED LYMPHOMA
- Xlife Sciences strengthens sustainability activities with ESG strategy
- Just – Evotec Biologics awarded contract from the U.S. Department of Defense under accelerated antibodies program
- APONTIS PHARMA announces cooperation to launch new Single Pill in Germany
- Epigenomics AG: Raise of earnings guidance for the current fiscal year 2022 due to currency gains and lower study costs
- DEFENCE THERAPEUTICS APPLAUDS UNITED STATES PRESIDENT BIDEN CANCER MOONSHOT INITIATIVE
- Formycon publishes details of a previously undisclosed pipeline project – FYB206 is a biosimilar candidate for Keytruda®* (pembrolizumab)
- Epigenomics Initiates prospective multi-center clinical trial for “Next-Generation” blood-based colorectal cancer test
- Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse, France (EU)
- AEVIS VICTORIA SA – AEVS.SW – Half-year results 2022: Net profit jumps to CHF 47.2 million
- Abivax presents first-half 2022 financial results and operations update
- Biophytis participates in H.C. Wainwright 24th Annual Global Investment Conference
- Kuros Biosciences announces successful CHF 6.0 million private placement
- Baader Bank initiates research coverage on Xlife Sciences
- Relief Reports Half-Year 2022 Results and Provides Corporate Update
- Newron provides H1 2022 results and updates on R&D and business activities
- TearClear Announces Positive Topline Results from CLEAR Phase 3 Study for the Treatment of Glaucoma with TC-002 (latanoprost ophthalmic solution 0.005%)
- Lowell Farms Inc. Commences Sales of Its New Preroll: the Lowell 35
- COMBINEDBrain Received the Global Genes 2022 Health Equity RARE Patient Impact Grant
- Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients
- Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
- International Meeting of the Society for Cardiac Robotic Navigation to Showcase Stereotaxis Technology and Its Clinical Value
- NRC Health Announces Sponsorship of Creative Learning Event Series Hosted by the Society for Participatory Medicine
- Wellframe and Linkwell Health Launch Wellsquared to Close the Gap Between Health Plans and their Members
- Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
- Icario’s Medicaid Redetermination Solution Helps Plans Prepare & Guide Members to Maintain Coverage
- Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial
- Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
- Santhera Announces Preliminary 2022 Half-year Financial Results Ahead of Full Report Publication by End of October
- Sirona Biochem Issues Corporate Update
- AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer
- Press Release: Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis
- Valneva Announces Launch of Approximately $40 Million in a Proposed Global Offering of American Depositary Shares and Ordinary Shares
- Aligos Therapeutics Files Response to Janssen Biopharma Lawsuit and Lodges Counterclaims Alleging Unfair Competition and Promissory Fraud
- Cellectis Appoints Mark Frattini, M.D., Ph.D. as Chief Medical Officer
- GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
- Idera Pharmaceuticals Acquires Aceragen
- Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer
- Morphic Congratulates Timothy A. Springer, PhD as 2022 Albert Lasker Basic Medical Research Award Honoree
- Florida Community Care Health Plan Reaches 20,000 Members
- NAFLD is Here and is Now a Canadian Epidemic
- Immunovant Announces IMVT-1402, a Next Generation Anti-FcRn
- Legent Imaging Increases Revenue, Decreases Rejected Claims with Exa Platform and Revenue Cycle Management Solution
- Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
- PolyPid Announces Eligibility for European Medicines Agency Centralized Procedure for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Surgery
- Oncotelic Presenting Data for OT101 Against Pancreatic Cancer (PDAC) at the SITC 37th Annual Meeting
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News